Performance of Saliva Samples for COVID-19 Diagnosis by Using the AllplexTM 2019-nCoV Assay Kit
- PMID: 33718401
- PMCID: PMC7943474
- DOI: 10.3389/fmed.2021.617399
Performance of Saliva Samples for COVID-19 Diagnosis by Using the AllplexTM 2019-nCoV Assay Kit
Abstract
Background: Although the nasopharyngeal swab (NPS) is the reference sampling method for the detection of SARS-Cov-2, it is not always possible to collect NPS in some patients. Saliva represents an interesting sampling method because it is less invasive and more convenient in patients with nasal or pharyngeal lesions. Objective: To compare the RT-qPCR test performances of saliva samples with nasal mid-turbinate swab (NMTS) and NPS samples in a cohort of ambulatory patients suspected of having COVID-19. Study Design: For each of the 112 enrolled patients, NPS, NMTS, and saliva samples were collected and tested for SARS-Cov-2 detection using three different target genes (RdRP, N and E genes) by RT-qPCR. Results: Among the positive samples (56/112), saliva samples showed a lower percentage of SARS-Cov-2 detection compared to NPS samples, (85.7 vs. 96.4%), while still a lower percentage was observed for NMTS samples (78.6%). In average, saliva samples showed higher Ct values for all tested target genes, compared to those from NPS and NMTS samples. Conclusions: By using the AllplexTM 2019-nCoV Assay Kit, saliva samples showed lower sensitivity for SARS CoV-2 compared to NPS samples; however, the not detected cases had lower viral burden in NPS samples (CT values >33) representing an interesting alternative sampling method in patients in which it is not possible to take a NPS sample.
Keywords: COVID-19; RT-qPCR; SAR-CoV-2; nasopharangeal swabs; saliva.
Copyright © 2021 Tapia, Marcia, Ivone, Nadia, Lesly, Camila, Valentina, Paula and Fabien.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.PLoS One. 2021 Feb 23;16(2):e0243183. doi: 10.1371/journal.pone.0243183. eCollection 2021. PLoS One. 2021. PMID: 33621263 Free PMC article.
-
Rapid screening of SARS-CoV-2 infection: Good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals.PLoS One. 2022 Apr 1;17(4):e0266375. doi: 10.1371/journal.pone.0266375. eCollection 2022. PLoS One. 2022. PMID: 35363814 Free PMC article.
-
Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients.Viruses. 2020 Nov 17;12(11):1314. doi: 10.3390/v12111314. Viruses. 2020. PMID: 33212817 Free PMC article.
-
Different Respiratory Samples for COVID-19 Detection by Standard and Direct Quantitative RT-PCR: A Literature Review.Iran J Pharm Res. 2021 Summer;20(3):285-299. doi: 10.22037/ijpr.2021.115458.15383. Iran J Pharm Res. 2021. PMID: 34903989 Free PMC article. Review.
-
Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2021 Feb 21;11(2):363. doi: 10.3390/diagnostics11020363. Diagnostics (Basel). 2021. PMID: 33670020 Free PMC article. Review.
Cited by
-
Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown.Adv Virol. 2024 Mar 29;2024:2993144. doi: 10.1155/2024/2993144. eCollection 2024. Adv Virol. 2024. PMID: 38584794 Free PMC article.
-
Review of COVID-19 testing and diagnostic methods.Talanta. 2022 Jul 1;244:123409. doi: 10.1016/j.talanta.2022.123409. Epub 2022 Mar 31. Talanta. 2022. PMID: 35390680 Free PMC article. Review.
-
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants.Vaccines (Basel). 2023 Feb 6;11(2):374. doi: 10.3390/vaccines11020374. Vaccines (Basel). 2023. PMID: 36851252 Free PMC article. Review.
-
Saliva as a diagnostic specimen for SARS-CoV-2 detection: A scoping review.Oral Dis. 2022 Nov;28 Suppl 2:2362-2390. doi: 10.1111/odi.14216. Epub 2022 Apr 27. Oral Dis. 2022. PMID: 35445491 Free PMC article.
References
-
- Centers for Disease Control and prevention (CDC) . Interim Guidelines for Clinical Specimens for COVID-19. Centers Dis Control Prev (2020). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim...
-
- World Health Organization (WHO) . Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases:Interim Guidance. World Heal Organ (2020). Available online at: https://apps.who.int/iris/handle/10665/331329
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous